Cargando…
TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients
The human endogenous retrovirus-K (HERV-K) and TAR DNA-binding protein 43 (TDP-43) have been associated with the pathophysiology of amyotrophic lateral sclerosis (ALS). Given these findings, we investigated the humoral response against HERV-K envelope surface (env-su) glycoprotein antigens and TDP-4...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623164/ https://www.ncbi.nlm.nih.gov/pubmed/34835107 http://dx.doi.org/10.3390/v13112301 |
_version_ | 1784605866133028864 |
---|---|
author | Simula, Elena Rita Arru, Giannina Zarbo, Ignazio Roberto Solla, Paolo Sechi, Leonardo A. |
author_facet | Simula, Elena Rita Arru, Giannina Zarbo, Ignazio Roberto Solla, Paolo Sechi, Leonardo A. |
author_sort | Simula, Elena Rita |
collection | PubMed |
description | The human endogenous retrovirus-K (HERV-K) and TAR DNA-binding protein 43 (TDP-43) have been associated with the pathophysiology of amyotrophic lateral sclerosis (ALS). Given these findings, we investigated the humoral response against HERV-K envelope surface (env-su) glycoprotein antigens and TDP-43 in the plasma of ALS patients and healthy controls (HCs). The measured levels of Abs against the different epitopes’ fragments were significantly elevated in ALS patients, both in long-survivor (LS) and newly diagnosed (ND) patients, compared to HCs. We observed a positive correlation between HERV-K and TDP-43 antibodies (Abs) levels, which seemed to strengthen with disease progression, that was not found in HCs. The TDP-43 and HERV-K epitopes identified in this study are highly immunogenic and recognized by the humoral response of ALS patients. Increased circulating levels of Abs directed against specific HERV-K- and TDP-43-derived epitopes could serve as possible biomarkers. |
format | Online Article Text |
id | pubmed-8623164 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86231642021-11-27 TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients Simula, Elena Rita Arru, Giannina Zarbo, Ignazio Roberto Solla, Paolo Sechi, Leonardo A. Viruses Article The human endogenous retrovirus-K (HERV-K) and TAR DNA-binding protein 43 (TDP-43) have been associated with the pathophysiology of amyotrophic lateral sclerosis (ALS). Given these findings, we investigated the humoral response against HERV-K envelope surface (env-su) glycoprotein antigens and TDP-43 in the plasma of ALS patients and healthy controls (HCs). The measured levels of Abs against the different epitopes’ fragments were significantly elevated in ALS patients, both in long-survivor (LS) and newly diagnosed (ND) patients, compared to HCs. We observed a positive correlation between HERV-K and TDP-43 antibodies (Abs) levels, which seemed to strengthen with disease progression, that was not found in HCs. The TDP-43 and HERV-K epitopes identified in this study are highly immunogenic and recognized by the humoral response of ALS patients. Increased circulating levels of Abs directed against specific HERV-K- and TDP-43-derived epitopes could serve as possible biomarkers. MDPI 2021-11-18 /pmc/articles/PMC8623164/ /pubmed/34835107 http://dx.doi.org/10.3390/v13112301 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Simula, Elena Rita Arru, Giannina Zarbo, Ignazio Roberto Solla, Paolo Sechi, Leonardo A. TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients |
title | TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients |
title_full | TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients |
title_fullStr | TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients |
title_full_unstemmed | TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients |
title_short | TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients |
title_sort | tdp-43 and herv-k envelope-specific immunogenic epitopes are recognized in als patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623164/ https://www.ncbi.nlm.nih.gov/pubmed/34835107 http://dx.doi.org/10.3390/v13112301 |
work_keys_str_mv | AT simulaelenarita tdp43andhervkenvelopespecificimmunogenicepitopesarerecognizedinalspatients AT arrugiannina tdp43andhervkenvelopespecificimmunogenicepitopesarerecognizedinalspatients AT zarboignazioroberto tdp43andhervkenvelopespecificimmunogenicepitopesarerecognizedinalspatients AT sollapaolo tdp43andhervkenvelopespecificimmunogenicepitopesarerecognizedinalspatients AT sechileonardoa tdp43andhervkenvelopespecificimmunogenicepitopesarerecognizedinalspatients |